In a recent retrospective study of 3819 patients who underwent LT, in downstaging groups, AFP < 100 ng/mL was the only independent predictor of HCC recurrence (HR 2.6; p = 0.02) [40]. This evidence concerns the gene AFP and hepatocellular carcinoma.